Kaine, J., Gladstein, G., Strusberg, I., Robles, M., Louw, I., Gujrathi, S., . . . Ludivico, C. (2011). Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: Impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study). BMJ Group.
Citação norma ChicagoKaine, Jeffrey, et al. Evaluation of Abatacept Administered Subcutaneously in Adults With Active Rheumatoid Arthritis: Impact of Withdrawal and Reintroduction On Immunogenicity, Efficacy and Safety (phase Iiib ALLOW Study). BMJ Group, 2011.
MLA citiranjeKaine, Jeffrey, et al. Evaluation of Abatacept Administered Subcutaneously in Adults With Active Rheumatoid Arthritis: Impact of Withdrawal and Reintroduction On Immunogenicity, Efficacy and Safety (phase Iiib ALLOW Study). BMJ Group, 2011.